Prioritizing quantum computing use cases in the drug discovery and development pipeline
Other text in scientific journal, 2025
molecular interactions
drug discovery and development
quantum computing
quantum chemistry
Author
Arseny Kovyrshin
Chalmers, Chemistry and Chemical Engineering
AstraZeneca AB
Lars Tornberg
AstraZeneca AB
Jason Crain
University of Oxford
IBM
Stefano Mensa
Hartree Centre
Ivano Tavernelli
IBM
Anders Broo
AstraZeneca AB
Drug Discovery Today
1359-6446 (ISSN) 18785832 (eISSN)
Vol. 30 3 104323Wallenberg Centre for Quantum Technology (WACQT)
Knut and Alice Wallenberg Foundation (KAW 2017.0449, KAW2021.0009, KAW2022.0006), 2018-01-01 -- 2030-03-31.
Subject Categories (SSIF 2025)
Computer Sciences
DOI
10.1016/j.drudis.2025.104323
PubMed
40054764